| Date Filed | Type | Description |
| 09/29/2023 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/30/2022 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 23,500 options to buy
@ $12.62, valued at
$296.6k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 2,500 shares
@ $12, valued at
$30k
Sold 1,227 shares
@ $13.54, valued at
$16.6k
|
|
| 10/16/2020 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 16,850 options to buy
@ $0 |
|
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.6, valued at
$52k
|
|
| 10/19/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/17/2017 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Disposed of 1,278,471 shares
@ $0
Granted 20,000 options to buy
@ $2.5, valued at
$50k
|
|
| 08/22/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/15/2017 |
SC 13D
| Hodges Philip reports a 8.5% stake in ALTIMMUNE, INC. |
| 05/08/2017 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,278,471 shares
@ $0
Granted 36,785 shares
@ $0
Granted 4,455 shares
@ $0 |
|
| 05/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |